CN102083964B - 与基于细胞的疗法相关的材料和方法 - Google Patents

与基于细胞的疗法相关的材料和方法 Download PDF

Info

Publication number
CN102083964B
CN102083964B CN2009801260075A CN200980126007A CN102083964B CN 102083964 B CN102083964 B CN 102083964B CN 2009801260075 A CN2009801260075 A CN 2009801260075A CN 200980126007 A CN200980126007 A CN 200980126007A CN 102083964 B CN102083964 B CN 102083964B
Authority
CN
China
Prior art keywords
cells
positive
cell
negative
pancreatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009801260075A
Other languages
English (en)
Chinese (zh)
Other versions
CN102083964A (zh
Inventor
保罗·希尔斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Glasgow
Original Assignee
University of Glasgow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Glasgow filed Critical University of Glasgow
Publication of CN102083964A publication Critical patent/CN102083964A/zh
Application granted granted Critical
Publication of CN102083964B publication Critical patent/CN102083964B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
CN2009801260075A 2008-05-09 2009-05-08 与基于细胞的疗法相关的材料和方法 Expired - Fee Related CN102083964B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5209808P 2008-05-09 2008-05-09
US61/052,098 2008-05-09
PCT/GB2009/001149 WO2009136168A1 (en) 2008-05-09 2009-05-08 Materials and methods relating to cell based therapies

Publications (2)

Publication Number Publication Date
CN102083964A CN102083964A (zh) 2011-06-01
CN102083964B true CN102083964B (zh) 2013-06-12

Family

ID=40935531

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801260075A Expired - Fee Related CN102083964B (zh) 2008-05-09 2009-05-08 与基于细胞的疗法相关的材料和方法

Country Status (5)

Country Link
US (2) US20110158961A1 (https=)
EP (1) EP2283115A1 (https=)
JP (1) JP2011519574A (https=)
CN (1) CN102083964B (https=)
WO (1) WO2009136168A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2845280A1 (en) 2010-08-13 2012-02-16 Paul Shiels Therapeutic uses of microvesicles and related micrornas
EP2864473B1 (en) * 2012-06-26 2019-08-21 Seraxis, Inc. Stem cells and pancreatic cells useful for the treatment of insulin-dependent diabetes mellitus
WO2014091373A1 (en) 2012-12-11 2014-06-19 The University Court Of The University Of Glasgow Cellular and molecular therapies for peripheral vascular disease
CN116121189A (zh) * 2016-03-30 2023-05-16 阿斯特利亚斯生物治疗股份公司 少突胶质细胞祖细胞组合物
WO2018034023A1 (ja) * 2016-08-18 2018-02-22 北海道公立大学法人札幌医科大学 寿命延長剤
WO2018187298A1 (en) 2017-04-04 2018-10-11 The Board Of Trustees Of The Leland Stanford Junior University Preparation, expansion, and uses of adult pluripotent stem cells
US20190085296A1 (en) * 2017-09-20 2019-03-21 Sergio Mora Method of expansion of human pancreas progenitor cells from stem cells using feeder-conditioned media
IL281628B2 (en) 2018-09-19 2025-06-01 Lineage Cell Therapeutics Inc Methods for differentiating pluripotent stem cells in dynamic suspension culture
CN112739208A (zh) 2018-09-21 2021-04-30 艾普斯丹医疗公司 人类多能成体干细胞
WO2020154533A1 (en) 2019-01-23 2020-07-30 Asterias Biotherapeutics, Inc. Dorsally-derived oligodendrocyte progenitor cells from human pluripotent stem cells
CN113710285A (zh) * 2019-03-26 2021-11-26 宾州研究基金会 用于治疗癌症的方法和材料

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878543B1 (en) * 1999-10-25 2005-04-12 Nsgene Sa Cultures of GFAP+ nestin+ cells that differentiate to neurons
WO2006120476A1 (en) * 2005-05-13 2006-11-16 The University Court Of The University Of Glasgow Materials and methods relating to cell based therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020012653A1 (en) * 1997-12-19 2002-01-31 Kevin Pang Bile duct progenitor cells and methods of use
CA2460985C (en) * 2001-09-20 2016-01-05 Anticancer, Inc. Nestin-expressing hair follicle stem cells
US20040029269A1 (en) * 2002-05-07 2004-02-12 Goldman Steven A Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878543B1 (en) * 1999-10-25 2005-04-12 Nsgene Sa Cultures of GFAP+ nestin+ cells that differentiate to neurons
WO2006120476A1 (en) * 2005-05-13 2006-11-16 The University Court Of The University Of Glasgow Materials and methods relating to cell based therapies

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Karen L Seeberger et al.Expansion of mesenchymal stem cells from human pancreatic ductal epithelium.《Laboratory Investigation》.2006,第86卷141-153. *

Also Published As

Publication number Publication date
WO2009136168A1 (en) 2009-11-12
US20130280219A1 (en) 2013-10-24
EP2283115A1 (en) 2011-02-16
US20110158961A1 (en) 2011-06-30
HK1157814A1 (en) 2012-07-06
CN102083964A (zh) 2011-06-01
JP2011519574A (ja) 2011-07-14

Similar Documents

Publication Publication Date Title
CN102083964B (zh) 与基于细胞的疗法相关的材料和方法
Oshima et al. Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting
Suzuki et al. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting
Hisatomi et al. Flow cytometric isolation of endodermal progenitors from mouse salivary gland differentiate into hepatic and pancreatic lineages
Yeung et al. Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines
Xie et al. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro
Dabeva et al. Hepatic stem cells and liver repopulation
Hoppo et al. Thy1‐positive mesenchymal cells promote the maturation of CD49f‐positive hepatic progenitor cells in the mouse fetal liver
US10093895B2 (en) Hepatic stellate cell precursors and methods of isolating same
Lin et al. Characterization of pancreatic stem cells derived from adult human pancreas ducts by fluorescence activated cell sorting
JP2011519574A5 (https=)
EP1896571B1 (en) Materials and methods relating to cell based therapies
Baek et al. Autonomous isolation, long‐term culture and differentiation potential of adult salivary gland‐derived stem/progenitor cells
Lo Nigro et al. Amnion-derived mesenchymal stromal/stem cell paracrine signals potentiate human liver organoid differentiation: translational implications for liver regeneration
Meivar-Levy et al. Human liver cells expressing albumin and mesenchymal characteristics give rise to insulin‐producing cells
Petrakova et al. Comparative analysis reveals similarities between cultured submandibular salivary gland cells and liver progenitor cells
Cancedda et al. The Phoenix of stem cells: pluripotent cells in adult tissues and peripheral blood
CN116585354A (zh) 胰腺干细胞及其用途
Stevenson et al. Isolation, characterization, and differentiation of thy1. 1-sorted pancreatic adult progenitor cell populations
US20050084964A1 (en) Stem cells originating in salivary duet epithelial cells and use thereof
Lan et al. Islet-like clusters derived from skeletal muscle-derived stem/progenitor cells for autologous transplantation to control type 1 diabetes in mice
Xiao et al. Establishing a human pancreatic stem cell line and transplanting induced pancreatic islets to reverse experimental diabetes in rats
Wang et al. Differentiation of CD24− pancreatic ductal cell‐derived cells into insulin‐secreting cells
JP4147306B2 (ja) 唾液腺由来の内胚葉系細胞および外胚葉系細胞の双方に分化可能な未分化な多分化能を有する新規細胞およびその細胞の調製方法
HK1157814B (en) Materials and methods relating to cell based therapies

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1157814

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1157814

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130612

Termination date: 20150508

EXPY Termination of patent right or utility model